Determination of Paraoxonase 1 Status Without the Use of Toxic Organophosphate Substrates
- 1 December 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Genetics
- Vol. 1 (2), 147-152
- https://doi.org/10.1161/circgenetics.108.811638
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?Free Radical Biology & Medicine, 2004
- Determination of Paraoxonase 1 Status and Genotypes at Specific Polymorphic SitesCurrent Protocols in Toxicology, 2004
- Paraoxonase Activity, But Not Haplotype Utilizing the Linkage Disequilibrium Structure, Predicts Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Expression of human paraoxonase (PON1) during developmentPharmacogenetics, 2003
- Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position −107, implicating the Sp1 transcription factorBiochemical Journal, 2003
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.JCI Insight, 1998
- Two Alleles of the Human Paraoxonase Gene Produce Different Amounts of mRNAArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.JCI Insight, 1997
- Paraoxonase protects against chlorpyrifos toxicity in miceToxicology Letters, 1995
- Serum paraoxonase status: A major factor in determining resistance to organophosphatesJournal of Toxicology and Environmental Health, 1993